Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.
Search for other papers by Angelica Lindén Hirschberg in
Google Scholar
PubMed
insulin and insulin-like growth factor I (IGF-I) and high levels of growth hormone and IGF-binding protein-1 ( Fig. 1 ) ( 4 , 7 , 8 ). Because IGF-I stimulates the release of both GnRH and LH, a decline in IGF-I activity may, at least in part, explain
Search for other papers by Maximilian Bielohuby in
Google Scholar
PubMed
Search for other papers by Martin Bidlingmaier in
Google Scholar
PubMed
Search for other papers by Uwe Schwahn in
Google Scholar
PubMed
other metabolic hormones. However, there are also examples from relatively stable circulating parameters in rodents, such as IGF-I, which seems to be only marginally affected by these variables (( 40 ) and unpublished observations). Unfortunately, there
Search for other papers by Henrik H Thomsen in
Google Scholar
PubMed
Search for other papers by Holger J Møller in
Google Scholar
PubMed
Search for other papers by Christian Trolle in
Google Scholar
PubMed
Search for other papers by Kristian A Groth in
Google Scholar
PubMed
Search for other papers by Anne Skakkebæk in
Google Scholar
PubMed
Search for other papers by Anders Bojesen in
Google Scholar
PubMed
Search for other papers by Christian Høst in
Google Scholar
PubMed
Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark
Search for other papers by Claus H Gravholt in
Google Scholar
PubMed
sex hormones, i.e. estrogen–progestin and testosterone, would impact circulating levels of sCD163. To that end we studied samples drawn from one study with KS, one with TS (24, 25, 26) , and one experimental study of acute male hypogonadism. We
Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, People’s Republic of China
Search for other papers by Xu Chen in
Google Scholar
PubMed
Search for other papers by Yi Tang in
Google Scholar
PubMed
Search for other papers by Shen Chen in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People’s Republic of China
Search for other papers by Wenhua Ling in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People’s Republic of China
Search for other papers by Qing Wang in
Google Scholar
PubMed
that bind to insulin-like growth factors I and II (IGF-I and IGF-II). IGFBP-2 has an RGD integrin-recognition motif and a heparin-binding domain ( 13 ). Studies have demonstrated that IGFBP-2 may be involved in the metabolic disease. A prospective study
Search for other papers by Peter Wolf in
Google Scholar
PubMed
Search for other papers by Yvonne Winhofer in
Google Scholar
PubMed
High Field MR Centre, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria
Search for other papers by Martin Krššák in
Google Scholar
PubMed
Search for other papers by Michael Krebs in
Google Scholar
PubMed
hyperlipidemia, hyperinsulinemia and hyperglycemia ( 71 ). It remains to be investigated whether this is due to increased lipid oxidation promoted by GH and IGF-1 or due to alterations in hepatic lipid metabolism, i.e. de novo lipogenesis and lipolysis
Search for other papers by Ja Hye Kim in
Google Scholar
PubMed
Search for other papers by Yunha Choi in
Google Scholar
PubMed
Search for other papers by Soojin Hwang in
Google Scholar
PubMed
Search for other papers by Gu-Hwan Kim in
Google Scholar
PubMed
Search for other papers by Han-Wook Yoo in
Google Scholar
PubMed
Search for other papers by Jin-Ho Choi in
Google Scholar
PubMed
rate or low IGF-1 levels. GH deficiency was defined as peak GH less than 10 ng/mL in both stimulation tests. The GnRH stimulation test was conducted using an i.v. bolus infusion of a standard dose of 60 μg/m 2 GnRH (Relefact ® , Sanofi
Search for other papers by Alicia Romano in
Google Scholar
PubMed
Search for other papers by Juan Pablo Kaski in
Google Scholar
PubMed
Search for other papers by Jovanna Dahlgren in
Google Scholar
PubMed
Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed
Search for other papers by Alberto Pietropoli in
Google Scholar
PubMed
Search for other papers by Tilman R Rohrer in
Google Scholar
PubMed
Search for other papers by Michel Polak in
Google Scholar
PubMed
weight SDS were calculated using age- and gender-specific national references. GH, growth hormone; IGF1, insulin-like growth factor I; SDS, standard deviation score. The most common concomitant medications were CNS stimulants (12
Search for other papers by Elin Kahlert in
Google Scholar
PubMed
Endokrinologikum Goettingen, Goettingen, Germany
Search for other papers by Martina Blaschke in
Google Scholar
PubMed
Search for other papers by Knut Brockmann in
Google Scholar
PubMed
Search for other papers by Clemens Freiberg in
Google Scholar
PubMed
Search for other papers by Onno E Janssen in
Google Scholar
PubMed
Search for other papers by Nikolaus Stahnke in
Google Scholar
PubMed
Search for other papers by Domenika Strik in
Google Scholar
PubMed
Search for other papers by Martin Merkel in
Google Scholar
PubMed
Search for other papers by Alexander Mann in
Google Scholar
PubMed
Search for other papers by Klaus-Peter Liesenkötter in
Google Scholar
PubMed
Endokrinologikum Goettingen, Goettingen, Germany
Search for other papers by Heide Siggelkow in
Google Scholar
PubMed
following cut-off values, where GPT >35 U/I, GOT >35 U/I, and gamma-GT >40 U/I were considered as increased. We recorded the values of glycated hemoglobin (HbA1c) in %, low-density lipoprotein (LDL) in mg/dL and high-density lipoprotein (HDL) in mg
Search for other papers by Thomas Reinehr in
Google Scholar
PubMed
Search for other papers by Martin Carlsson in
Google Scholar
PubMed
Search for other papers by Dionisios Chrysis in
Google Scholar
PubMed
Search for other papers by Cecilia Camacho-Hübner in
Google Scholar
PubMed
( 14 ). It is well known that GH and insulin-like growth factor (IGF-I) have also an impact on bone age ( 4 , 26 , 27 ). Therefore, deficiencies in GH and IGF-I lead to growth impairment and bone age delay, while overproduction or administration of GH
Berlin Institute of Health (BIH), Berlin, Germany
Department of Nephrology, School of Medicine, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany
Search for other papers by Eric Seidel in
Google Scholar
PubMed
Search for other papers by Gudrun Walenda in
Google Scholar
PubMed
Core Unit Bioinformatics, Berlin Institute of Health, Berlin, Germany
Search for other papers by Clemens Messerschmidt in
Google Scholar
PubMed
Core Unit Bioinformatics, Berlin Institute of Health, Berlin, Germany
Search for other papers by Benedikt Obermayer in
Google Scholar
PubMed
Search for other papers by Mirko Peitzsch in
Google Scholar
PubMed
Search for other papers by Paal Wallace in
Google Scholar
PubMed
Search for other papers by Rohini Bahethi in
Google Scholar
PubMed
Search for other papers by Taekyeong Yoo in
Google Scholar
PubMed
Search for other papers by Murim Choi in
Google Scholar
PubMed
Search for other papers by Petra Schrade in
Google Scholar
PubMed
Search for other papers by Sebastian Bachmann in
Google Scholar
PubMed
Search for other papers by Gerhard Liebisch in
Google Scholar
PubMed
Search for other papers by Graeme Eisenhofer in
Google Scholar
PubMed
Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
Search for other papers by Dieter Beule in
Google Scholar
PubMed
Berlin Institute of Health (BIH), Berlin, Germany
Department of Nephrology, School of Medicine, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany
Search for other papers by Ute I Scholl in
Google Scholar
PubMed
with 50 µM mitotane and performed electron microscopy ( Fig. 2 , Supplementary Fig. 2). Untreated nonresistant ( Fig. 2A , B and C ) and resistant clones ( Fig. 2G , H and I ) displayed normal cellular and mitochondrial morphology with frequent